Bicycle Therapeutics plc
BCYC
$4.01
-$0.18-4.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 17.25% | -201.80% | 65.90% | 25.14% | -29.95% |
| Total Depreciation and Amortization | -5.49% | -15.49% | -23.92% | 3.54% | 3.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.61% | -46.47% | 43.22% | -4.16% | 9.83% |
| Change in Net Operating Assets | 45.27% | 0.81% | 42.25% | -386.71% | 86.96% |
| Cash from Operations | 24.75% | -240.77% | 72.82% | 2.22% | 15.73% |
| Capital Expenditure | 62.83% | -24.22% | 14.84% | -35.34% | 17.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 62.83% | -24.22% | 14.84% | -35.34% | 17.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 22.73% | -37.50% | -54.84% | 32.61% | -6.98% |
| Issuance of Common Stock | -91.67% | -63.64% | 3,200.00% | 0.00% | -50.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.41% | -260.00% | 50.00% | 33.33% | -9.76% |
| Foreign Exchange rate Adjustments | 97.48% | -775.68% | 82.23% | -169.12% | 286.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.20% | -240.51% | 72.44% | -2.24% | 17.36% |